Document:

Ex. 10.1
                             Hand Brand Distribution
                              9845 N.E. 2nd Avenue
                           Miami Shores, Florida 33138
                                 (305) 759-8710

                                January 14, 2002

GeneThera, Inc.
12635 Montview Blvd, Suite 211
Aurora, Colorado 80010
Attn:  Mr. Antonio Milici, Chairman of the Board of Directors

Ladies and Gentlemen:

On behalf of the Board of Directors of Hand Brand Distribution,  Inc., a Florida
corporation  ("HBDB"),  I would  like to  advise  the  Board  of  Directors  and
shareholders of GeneThera, Inc. ("the Company") that HBDB wishes to acquire 100%
of the  Company's  outstanding  capital stock  ("Stock"),  on and subject to the
terms and  conditions  below (the  "Acquisition").  In order to complete our due
diligence review of GeneThera's  operations,  financial condition and prospects,
as  well  as  those  of  its  subsidiaries  and  affiliates,   we  will  require
approximately two additional days.

We believe that HBDB has taken the necessary  steps to effectively  complete the
Acquisition. These actions include:

1.   On January 11, 2002,  our Board of  Directors  voted to reverse our capital
     stock on an eight share for each one share held (8:1). On January 15, 2002,
     we filed  Articles of  Amendment  to reflect the  reverse  split  effective
     January  15, 2002 with the Florida  Secretary  of State.  Exhibit A to this
     letter includes a copy of the Articles of Amendment.

2.   At  the  Board  Meeting  today,  our  Board  of  Directors  we  unanimously
approved several actions relative to the Acquisition, including:

     A.   Accepting an Private Equity Line of Credit facility  ("Facility") for
          $30.0 million from Prima Capital Growth Fund LLC. In  consideration
          for the Facility,  Prima  Capital will receive  equity  in HBDB at a
          discounted price per share.     Prima  Capital has  conditioned  the
          Facility on our  successfully  completing  the  Acquisition.  A copy
          of  the  Facility documents are attached as Exhibit B.

     B.   Selling  the assets of Family  Health  News,  Inc.,  our  wholly-owned
          subsidiary.  The sale of Family  Health will leave our  balance  sheet
          with  $100,000 of debt and nominal  assets.  Based on Florida law, the
          sale of this subsidiary requires  shareholder  approval.  This will be
          done at our Annual Meeting of  Shareholders to be held on February

<PAGE>

          24, 2002. We have already  obtained  Unanimous  Consent from more than
          50% of our outstanding votes, which ensures that this will be sold. As
          such, we are required to file an Information Statement and not a Proxy
          Statement with the Securities and Exchange Commission.  Exhibit C is a
          copy of the Asset  Purchase  Agreement  between HBDB and Family Health
          News.

    C.    Entering into a $500,000  Convertible  Note  Agreement and  Promissory
          Note, due January 2005 and convertible into HBDB common stock at $1.00
          per share. We intend to use the funds for this Note to restructure the
          $100,000  discussed  above and to allow  continued  borrowing  for our
          short term cash needs until the Private  Equity Line can be registered
          with the SEC and become  effective.  See Exhibit D for the form of the
          Agreement and Note.

Our proposed terms of the Acquisition are as follows:

1.   HBDB  would  acquire  all of the  Stock  from  the  GeneThera  shareholders
     pursuant to a merger of GeneThera with HBDB (the "Merger", in exchange for
     the common stock of HBDB.  All of the Stock must be validly  issued,  fully
     paid and  non-assessable  and  shall be free of any lien,  encumbrances  or
     options.  See Exhibit E for the definitive  agreements titled "Common Stock
     Purchase Agreement" to be executed.  Prior to the merger, we expect to have
     approximately  348,563  shares of HBDB common  stock  outstanding,  100,000
     shares subject to conversion with regard to the Convertible  Note described
     above, and warrants issued to Prima in connection with the Facility.  Based
     upon information available to HBDB, which is subject to verification, as to
     the currently  outstanding  Stock, the exchange rate would be approximately
     3.0 shares of HBDB for each share of GeneThera.

2.   GeneThera  shareholders  (i) would own an aggregate of 8,937,150  shares of
     the  common  stock of HBDB,  subject  to  dilution  as a result  of  equity
     contributed to HBDB and the provisions in each purchase  agreement with the
     Shareholders.  Attached is Exhibit E, which is a  certified  list of all of
     the GeneThera shareholders and their shareholdings..

3.   The  closing of the Merger  would occur on or about  Thursday,  January 17,
     2002, assuming all GeneThera shareholders consent to the Merger.

Although  there shall be no obligation to do so, it is the intent of the parties
to try and execute all  documentation  by January 25, 2002, other than documents
that require shareholder approval.

It is  understood  that the  terms of this  letter  are  binding  upon  HBDB and
GeneThera  and is  acceptable  for the  exchange  of the Stock  for HBDB  common
shares.  The ensuing  discussions  between  our  respective  representatives  or
GeneThera  shareholders and their

<PAGE>

representatives  are confidential and will not be disclosed in any manner except
as may be required by law.

If  this  Letter  of  Intent  accurately  reflects  your  understanding  of  the
Transaction,  please so indicate by faxing a fully  executed copy of this letter
to us no later than January 15, 2002.

Sincerely,

Hand Brand Distribution Inc.

By: ---------------------------------------------------
      John Taggert, President and Chairman of the Board

Exhibits:
---------
A - Reverse Stock Split
B - Private Equity Line of Credit
C - Sale of Family Health News, Inc.
D - Convertible Note Agreement
E - Certified GeneThera Shareholder List

GeneThera, Inc. & Shareholders
------------------------------
Accepted and Agreed:
--------------------

------------------------------
Chairman of Board

<PAGE>Ex. 10.2
                             Hand Brand Distribution
                              9845 N.E. 2nd Avenue
                           Miami Shores, Florida 33138
                                 (305) 759-8710

                                February 25, 2002

GeneThera, Inc.
12635 Montview Blvd, Suite 211
Aurora, Colorado  80010
Attn:  Mr. Antonio Milici

Dear Tony:

As of today's date, we have acquired 2,768,650 of the 2,979,050 common shares of
GeneThera, Inc. We agree to extend the stock exchange offer on the remaining
210,400 shares of GeneThera, Inc., which we have not yet acquired until March
15, 2002, when the offer shall expire. We will reserve 631,200 of our authorized
and not yet issued shares until that date.

Further, this letter shall serve as our agreement among the undersigned that all
terms and conditions of the letter of agreement dated January 14, 2002 have been
satisfied in full.

Effective immediately, we shall consider our transaction closed and all
conditions met.

The representations and warranties contained in the Stock Purchase Agreements
shall survive this closing.

The above accurately reflects the understandings with respect to the
transaction.

Sincerely,

Hand Brand Distribution Inc.

By: /s/
    ------------------------
           President

<PAGE>

GeneThera, Inc. & Selling Shareholders of GeneThera, Inc.
Accepted and Agreed:

/s/
------------------------------------
Chairman of Board

/s/
------------------------------------
Tony Milici, individually as majority
and controlling shareholderEx. 10.3
                                                                 EXECUTION COPY

                         COMMON STOCK PURCHASE AGREEMENT

                                     BETWEEN

                          HAND BRAND DISTRIBUTION, INC.

                                       AND

                                   TONY MILICI

                                January 23, 2002

<PAGE>

                                  COMMON STOCK
                               PURCHASE AGREEMENT

     This Common Stock Purchase Agreement (this "Agreement") is made as of the
23rd day of January, 2002, between HAND BRAND DISTRIBUTION, INC., a Florida
corporation ("HBDB") and Tony Milici ("Seller").

                                    RECITALS:

     WHEREAS, Seller owns 1,545,000 shares of common stock, par value, .01 per
share (the "Common Stock") of the outstanding stock of GeneThera, Inc., a
corporation organized under the laws of the State of Colorado (the "Company").
The Common Stock owned by Seller represents 51.86% of the capital stock issued
and outstanding of the Company.

     WHEREAS, Seller wishes to sell, and HBDB wishes to purchase, the Common
Stock for 4,635,000 shares of the common stock of HBDB (the "HBDB Shares").

     NOW, THEREFORE, in consideration of the premises and of other good and
valuable consideration, receipt of which is acknowledged, it is hereby agreed as
follows:

     1. Purchase and Sale of the Common Stock

          1.1 Sale of the Common Stock.

          In consideration of the issuance and sale of the HBDB Shares and in
reliance on the representations, warranties and undertakings of HBDB herein,
Seller shall sell and transfer to HBDB on the Closing Date, and HBDB shall
purchase from Seller, the Common Stock, free and clear of all liens, claims,
pledges, charges, agreements, and encumbrances of any kind whatsoever ("Liens").
In consideration of the transfer and sale of the Common Stock to HBDB and in
reliance on the representations, warranties and undertakings of Seller herein
contained, HBDB shall sell and issue to Seller, on the Closing Date, and Seller
shall purchase from HBDB, the HBDB Shares free and clear of all Liens.

          1.2 Closing.  Subject to the conditions set forth below, the purchase
and sale of the Common Stock shall take place at the offices of Proskauer Rose
LLP, 1585 Broadway, New York, New York 10036, thirty (30) days after the
execution of this Agreement, or at such other time and place as HBDB and Seller
mutually agree upon in writing (which time and place are designated as the
"Closing" and the "Closing Date"). If the Closing does not occur thirty five
(35) days after the execution of this Agreement, either party may terminate this
Agreement by providing the other party written notice of such termination. At
the Closing, HBDB shall deliver to Seller, a stock certificate in the name of
Seller representing the HBDB Shares (which shall have endorsed thereon the
legend referred to in Section 2.21(h) hereof). At the Closing, Seller shall
deliver to HBDB a stock certificate in the name of HBDB representing the Common
Stock owned by Seller free of any legends (except for the legend described in
Section 2.21(h) hereof) or Liens of any kind, together with stock powers
executed by him with the signatures thereon

<PAGE>

guaranteed by a member of the New York Stock Exchange or a national bank in the
United States

     2. Representations, Warranties and Agreements of Seller. Seller hereby
represents and warrants to, and agrees with, HBDB, except as set forth on the
Schedule of Exceptions furnished to HBDB and attached hereto as Schedule 1,
specifically identifying the relevant subsection hereof, which exceptions shall
be deemed to be representations and warranties as if made hereunder, as follows:

          2.1 Organization, Good Standing and Qualification. The Company, is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Colorado. The Company has all requisite power and authority to
carry on its business as now conducted and as proposed to be conducted. The
Company is duly qualified to transact business and is in good standing in each
jurisdiction in which the failure so to qualify could have a material adverse
effect on its business, properties, operations, earnings, assets, liabilities,
condition (financial or otherwise) (collectively, "Condition").

          2.2 Capitalization. The authorized capital stock of the Company
consists of and upon the consummation of the Closing shall consist of 10,000,000
shares of common stock, $.01 par value per share, of which 2,979,050 are issued
and outstanding. All the outstanding shares have been duly and validly issued,
are fully paid and non-assessable. Except as set forth in Part 2.2 of Schedule
1, the Company does not have outstanding any securities convertible into or
exchangeable for its capital stock or outstanding any rights to subscribe for or
to purchase, or any options for the purchase of, or any agreements providing for
the issuance (contingent or otherwise) of, or any calls, commitments or claims
of any character relating to, its capital stock. There are no agreements among
the shareholders of the Company with respect to the voting or transfer of the
capital stock or to change control of the Company and none of its shareholders
has preemptive rights. Schedule 2 hereto includes a complete and correct list as
of immediately prior to the Closing, of the name of each of the Company
shareholders and the number of shares of stock owned by such shareholder. Seller
is the record and beneficial owner of the Common Stock, which are free and
clear, and which will be at the Closing free and clear, from any Liens. Except
as set forth in part 2.2 of Schedule 1, there is not outstanding any security,
option, warrant, right, agreement, understanding or commitment of any kind
entitling any person or entity to acquire any of the Common Stock. The Common
Stock has not been registered with the SEC or any state regulatory authority and
no such registration is required.

          2.3 Authority; Execution and Delivery; Requisite Consents,
Nonviolation.

          Seller has, and at the Closing will have, all requisite power and
authority to execute, deliver and perform this Agreement and each other document
or instrument executed by him, in connection herewith or therewith or pursuant
hereto or thereto and to consummate the transactions contemplated hereby and
thereby. The execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated hereby and thereby have been duly
and validly authorized by all necessary action on the part of Seller. This
Agreement is duly executed and delivered by Seller and is the legal, valid and
binding obligation of Seller, enforceable against him in accordance with its
terms, except as the enforceability thereof may be limited by bankruptcy,
insolvency, moratorium or other similar laws affecting the enforceability

<PAGE>

of creditors' rights in general or by general principles of equity. As to the
Company and Seller, the execution, delivery and performance of this Agreement,
the consummation by Seller of the transactions contemplated hereby and thereby
(including, without limitation, the offer, sale and delivery by Seller of the
Common Stock) will not (a) except as set forth in Part 2.3 of Schedule 1,
require the consent, license, permit, waiver, approval, authorization or other
action of, by or with respect to, or registration, declaration or filing with,
any court or governmental authority, department, commission, board, bureau,
agency or instrumentality, domestic or foreign ("Governmental Authority") or any
other individual, partnership, corporation, unincorporated organization or
association, limited liability company, trust or other entity (collectively, a
"Person"); (b) contravene (i) any requirement of law to which the Company or
Seller is subject, including without limitation the securities laws of any
domestic or foreign jurisdiction or the rules or regulations of any governmental
entity or self regulatory body nor (ii) any judgment, decree, franchise, order
or demand applicable to him or the Company; (c) conflict or be inconsistent with
or result in any breach of the terms, covenants, conditions or provisions of, or
constitute a default under, or result in the creation or imposition of (or the
obligation to create or impose) any Lien upon any of his or the Company's
properties or assets pursuant to the terms of any indenture, mortgage, deed of
trust agreement or other instrument to which the Company or Seller is a party or
bound or to which the Company or Seller may be subject or violate any provision
of the Company's organization documents. Neither the Company nor Seller is in
default with respect to any applicable statute, rules, writ, injunction, decree,
order or regulation of any Governmental Authority having jurisdiction over any
of them which is likely to adversely affect their ability to perform their
obligations hereunder and entering into this Agreement will not violate any of
them.

          2.4 Subsidiaries. Schedule 3 sets forth (i) the name of each
corporation of which the Company owns, directly or indirectly, shares of capital
stock (collectively, Subsidiaries and individually, Subsidiary) (ii) the name of
each corporation, partnership, joint venture or other entity (other than the
Subsidiaries) in which the Company has, or pursuant to any agreement has the
right to acquire at any time by any means, directly or indirectly, an equity
interest or investment; (iii) in the case of each of such corporations described
in clauses (i) and (ii) above, (A) the jurisdiction of incorporation, (B) the
capitalization thereof and the percentage of each class of capital voting stock
owned by the Company, (C) a description of any contractual limitations to vote
or alienate such securities, (D) a description of any outstanding options or
other rights to acquire securities of or interest in such corporation, and (E) a
description of any other contractual obligation or impediment which would
materially limit or impair the Company's, ownership of such entity or interest
or its ability effectively to exercise the full rights of ownership of such
entity or interest; and (iv) in the case of each of such unincorporated
entities, information substantially equivalent to that provided pursuant to
clause (iii) above with regard to corporate entities.

          Each Subsidiary is a corporation duly organized, validly existing and
in good standing under the laws of its jurisdiction of incorporation and has all
requisite corporate power and authority to own its properties and assets and to
conduct its business as now conducted. Each Subsidiary is duly qualified to do
business as a foreign corporation in every jurisdiction in which the character
of the properties owned or leased by it or the nature of the business conducted
by it makes such qualification necessary, except where such failure would not
have a material adverse effect on the Subsidiary's financial condition, results
of operation or business.

<PAGE>

Each Subsidiary is duly qualified to do business in good standing in each
jurisdiction where the nature of the business conducted by the Company or the
ownership or leasing of their respective properties makes such qualification and
being in good standing necessary, except where the failure to be so qualified
and in good standing will not have a material adverse effect on the business,
operations, properties, assets, condition or results of operation of the
Company. All the outstanding shares of capital stock of each Subsidiary owned by
the Company have been duly authorized and validly issued, are fully paid and
non-assessable, and are owned of record and beneficially, directly or
indirectly, by the Company, free and clear of any Liens, or other legal or
equitable encumbrances, limitations or restrictions. Except as set forth in
Section 2.4 of Schedule 1, there are no outstanding options, warrants,
agreements, conversion rights, preemptive rights or other rights to subscribe
for, purchase or otherwise acquire any issued or unissued shares of capital
stock of any Subsidiary.

          2.5 Financial Information. Financial Statements. Attached hereto as
Schedule 4 (the "Financial Statements") for the Company, are (a) reviewed
balance sheets at December 31, 2000, December 31, 1999 and December 31, 1998 and
related statements of income, changes in stockholders' equity, and cash flows
for the same periods (the "Reviewed Financial Statements") and (b) unaudited
balance sheets of the Company and related unaudited statements of operations,
stockholders equity and cash flows for the period ended October 31, 2001 (the
"Unaudited Financial Statements") and together with the Reviewed Financial
Statements, (the "Historical Financial Statements"). Except as described in
Schedule 4, the Historical Financial Statements were prepared in accordance with
generally accepted accounting principles ("US GAAP") applied on a consistent
basis with prior periods and, present fairly, in all material aspects, the
financial position, results of operations and changes in financial position of
the Company as of such dates.

          There is no Indebtedness (as defined below) or other liabilities or
obligations of the Company, whether absolute, accrued, contingent or otherwise,
that are required in accordance with US GAAP to be, but are not, fully reflected
or reserved against in the Historical Financial Statements or in notes thereto,
except for liabilities that may have arisen in the ordinary and usual course of
business and consistent with past practices or which are disclosed in Schedule
4. For this purpose, Indebtedness is defined as any contract, commitment or
agreement under which it has outstanding Indebtedness or for the deferred
purchase price of property in excess of US$10,000 or has the right or obligation
to incur any such Indebtedness or obligation, or made any loan or advance to any
person other than advances to employees for business expenses not exceeding
US$10,000 in the aggregate. Indebtedness shall also mean, all obligations with
respect to borrowed money, contingent and otherwise, which, in accordance with
US GAAP, should be classified on the obligor's balance sheet as liabilities, or
to which reference should be made by footnotes thereto, including without
limitation, in any event and whether or not so classified (i) all debt and
similar monetary obligations, whether direct or indirect; (ii) all liabilities
secured by any mortgage, pledge, security interest, lien, charge or other
encumbrance existing on property owned or acquired subject thereto, whether or
not the liability secured thereby shall have been assumed; (iii) all guaranties,
endorsements and other contingent obligations whether direct or indirect in
respect of Indebtedness or performance of others, including any obligation to
supply funds to or in any manner to invest in, directly or indirectly, the
debtor, to purchase Indebtedness, or to assure the owner of Indebtedness against
loss, through

<PAGE>

an agreement to purchase goods, supplies or services for the purpose of enabling
the debtor to make payment of the Indebtedness held by such owner or otherwise;
and (iv) obligations to reimburse issuers of any letters of credit.

          2.6 Certain Changes or Events. Since June 30, 2001, (i) there has been
no change in the Condition of the Company, except for changes which have not
been, in the aggregate, materially adverse to the Company; (ii) there has been
no change of Laws (as defined in Section 2.12 hereof), no revocation or change
in any Contract (as defined in Section 2.8 hereof) or Permit (as defined in
Section 2.12 hereof) or right to do business, and no other event or occurrence
of any character, whether or not insured against, which has resulted, or could
reasonably be expected to result, in a material adverse change in the Condition
of the Company; (iii) the Company has not authorized or made any distributions,
or declared or paid any dividends, upon or with respect to any of its capital
stock, or other equity interests, nor has the Company redeemed, purchased or
otherwise acquired, or issued or sold, any of its capital stock or other equity
interests; (iv) Except as set forth in part 2.6 of Schedule 1, the Company has
not entered into any material transaction, other than in the ordinary course of
business and consistent with past practice; (v) except as set forth in Schedule
4 the Company has not incurred any Indebtedness for borrowed money or made any
loans or advances to any Person; (vi) there has been no waiver by the Company of
a material right or of a material debt owed to it; (vii) the Company has not
failed to satisfy or discharge any Lien, except in the ordinary course of
business and which is not material to the Condition of the Company (as such
business is presently conducted and as it is proposed to be conducted); and
(viii) there has been no material change in any compensation, arrangement or
agreement with any employee, director, shareholders or Affiliate (as defined
below). "Affiliate" of a specified Person shall mean a Person that directly, or
indirectly through one or more intermediaries, controls or is controlled by, or
is under common control with, the Person specified and, as to any Person that is
an individual, such individual's spouse, parents, grandparents, siblings and
lineal descendants.

          2.7 Title to Assets. The Company has good and marketable title to all
of its assets and properties, free and clear of any Liens. With respect to any
assets or properties the Company leases, the Company holds a valid and
subsisting leasehold interest therein, free and clear of any Liens, is in
compliance, in all material respects, with the terms of the applicable lease,
and enjoys peaceful and undisturbed possession under such lease. All of the
assets and properties of the Company that are necessary for the conduct of its
business as presently conducted or as proposed to be conducted by the Company
are in good operating condition and repair, subject to ordinary wear and tear.

          2.8 Contracts. The Company is not a party to, nor is either of its
assets or properties bound by, or subject to, any contracts, agreements, notes,
instruments, franchises, leases, licenses, commitments, arrangements or
understandings, written or oral (collectively, "Contracts") of the following
types, except for those (the "Scheduled Contracts") listed in Part 2.8 of
Schedule 1 hereto:

               (a) any Contracts pursuant to which the Company, or another party
thereto, is obligated to pay in excess of $10,000;

<PAGE>

               (b) any Contracts pursuant to which the Company acquired the
right to use any Intellectual Property (as defined in Section 2.9 hereof) or
information that is material to or necessary in the business of the Company, or
pursuant to which the Company has granted to others the right to use, or which
otherwise relates to, its Intellectual Property;

               (c) any Contracts (other than advances of expenses to employees
in the ordinary course of business) involving loans, loan agreements, debt
securities, mortgages, deeds of trust, security agreements, suretyships or
guarantees;

               (d) any Contracts between the Company, on the one hand, and any
of their respective officers, directors, employees or Persons that beneficially
own in excess of 5% of the outstanding equity interest of the Company (each a
"Principal Owner"), or any Affiliate or relative, or Affiliate of a relative, of
any of the foregoing, on the other;

               (e) any deferred compensation agreements, bonus, pension, profit
sharing, stock option and incentive plans or arrangements, hospitalization,
medical and insurance plans, agreements and policies, retirement and severance
plans and other employee compensation policies and agreements affecting
employees of the Company;

               (f) any Contracts with any labor union affecting employees of the
Company;

               (g) any Contracts which restrict the Company from freely engaging
in business or competing anywhere; or

               (h) any Contracts which otherwise are material to the Condition
of the Company.

          All of the Scheduled Contracts are in full force and effect and
constitute legal, valid and binding obligations of the Company and shall be as
of the Closing performed in all material respects all obligations required to be
performed by it on or before the date hereof under the Scheduled Contracts, and
no violation exists in respect thereof on the part of the Company or, any other
party thereto; none of the Scheduled Contracts is currently being renegotiated;
and the validity, effectiveness and continuation of all Scheduled Contracts will
not be materially adversely affected by the transactions contemplated by this
Agreement.

          2.9 Intellectual Property.

               (a) The Company owns all of the Intellectual Property (as defined
below) and has all the Intellectual Property necessary to currently conduct its
business and its properties. Part 2.9 of Schedule 1 hereto is a true, correct
and complete list of (i) all inventions (whether patent able or unpatentable and
whether or not reduced to practice), all improvements thereto, and all patents,
patent applications, and patent disclosures, together with all reissuances,
continuations, continuations-in-part, revisions, extensions, and reexaminations
thereof, (ii) all trademarks, service marks, trade dress, logos, trade names,
and corporate names, together with all translations, adaptations, derivations,
and combinations thereof and including all goodwill associated therewith, and
all applications, registrations, and renewals in connection therewith, (iii) all
copyrightable works, all copyrights, and all applications, registrations, and
renewals in

<PAGE>

connection therewith, (iv) all mask works and all applications, registrations,
and renewals in connection therewith, (v) all trade secrets and confidential
business information (including ideas, research and development, know-how,
formulas, compositions, manufacturing and production processes and techniques,
technical data, designs, drawings, specifications, customer and supplier lists,
pricing and cost information, and business and marketing plans and proposals),
(vi) all computer software (including data and related documentation), (vii) all
other proprietary rights, and (viii) all copies and tangible embodiments thereof
(in whatever form or medium) (collectively, the "Intellectual Property") of any
kind in which the Company or any of its Affiliates or Subsidiaries have an
interest or which is otherwise used in, or relates to the business of the
Company or ay of its Affiliates or Subsidiaries. Part 2.9 of Schedule 1 hereto
contains a true, correct and complete list of all licenses or agreements that in
any way affect the rights of the Company to any of the Intellectual Property or
any trade secret material of the Company (the "Intellectual Property Licenses").

               (b) The Company is the sole and exclusive owner, free and clear
of all Liens, and has all right, title and interest in all of the Intellectual
Property listed in Part 2.9 of Schedule 1 hereto. With respect to any
Intellectual Property or trade secret necessary to conduct its business, the
Company or any of its Affiliates or Subsidiaries own or have the exclusive right
to use such Intellectual Property or trade secret in its business. The Company
or any of its Affiliates or Subsidiaries own or possess sufficient licenses or
other rights to use all Intellectual Property covered by its patents that are
necessary to conduct the business of the Company or any of its Affiliates or
Subsidiaries as now being conducted and as proposed to be conducted by the
Company or any of its Affiliates or Subsidiaries.

               (c) Each of the Intellectual Property Licenses is in full force
and effect and constitutes a legal, valid, binding and enforceable obligation in
accordance with its terms against the Company or any of its Affiliates or
Subsidiaries. The Company or any of its Affiliates or Subsidiaries has performed
all obligations imposed upon it under each of the Intellectual Property Licenses
to which it is a party. Neither the Company nor any of its Affiliates or
Subsidiaries, is in default thereunder or is there any event that with notice or
lapse of time, or both, would constitute a default thereunder. The Company or
any of its Affiliates or Subsidiaries have not received any notice that any
other party to any of the Intellectual Property Licenses intends to cancel,
terminate or refuse to renew the same or to exercise or decline to exercise any
option or other right thereunder. No licenses, sublicenses, covenants or
agreements have been granted or entered into by the Company or any of its
Affiliates or Subsidiaries in respect of any of the Intellectual Property or any
trade secret material of the Company, except the Intellectual Property Licenses.
No director, officer, shareholder, employee or other Affiliate of the Company or
any of its Affiliates or Subsidiaries owns, directly or indirectly, in whole or
in part, any of the Intellectual Property or any trade secret material of the
Company or any of its Affiliates or Subsidiaries. None of the officers,
employees, consultants, distributors, agents, representatives or advisors of the
Company or any of its Affiliates or Subsidiaries have entered into any agreement
relating to the Company's business regarding know-how, trade secrets, assignment
of rights in inventions, or prohibition or restriction of competition or
solicitation of customers, or any other similar restrictive agreement or
covenant, whether written or oral, with any Person other than the Company.

<PAGE>

               (d) The consummation of the transactions contemplated hereby will
not alter or impair the rights of the Company or any of its Affiliates or
Subsidiaries to any of the Intellectual Property, any trade secret material to
the Company or any of its Affiliates or Subsidiaries, or under any of the
Intellectual Property Licenses and each item of Intellectual Property owned or
used by the Company immediately prior to the Closing hereunder will be owned or
available for use by HBDB on identical terms and conditions immediately
subsequent to the Closing.

               (e) Neither the Company nor Seller, nor any Affiliates, officers,
shareholders, directors or employees of each of them has disclosed any
proprietary information relating to the Intellectual Property or the
Intellectual Property Licenses to any person other than HBDB and the employees,
consultants, accountants, lawyers and other advisors of the Company. Each of the
Company, Seller and any Affiliates, officers, shareholders, directors or
employees of each of them has at all times maintained reasonable procedures to
protect and have enforced all trade secrets of the Company. Each of the Company,
Seller and any Affiliates, officers, shareholders, directors or employees of
each of them has disclosed trade secrets to other Persons solely as required for
the conduct of the Company's business and solely under nondisclosure agreements
that are enforceable by the Company. The Company or any of its Affiliates or
Subsidiaries is not under any contractual or other obligation to disclose any
proprietary information relating to the Intellectual Property, any trade secret
material of the Company or the Intellectual Property Licenses, nor is any other
party to the Intellectual Property Licenses under any such obligation to
disclose proprietary information included in or relating to Intellectual
Property, any trade secret material to the Company or the Intellectual Property
Licenses to any Person, and no event has taken place, including the execution
and delivery of this Agreement and the transactions contemplated hereby or any
related change in the business activities of the Company, that would give rise
to such obligation.

               (f) Neither the Company nor Seller has interfered with, infringed
upon, misappropriated, or otherwise come into conflict with any Intellectual
Property rights of third parties, and none of Seller, the directors and officers
(and employees with responsibility for Intellectual Property matters) of the
Company has ever received any charge, complaint, claim, demand, or notice
alleging any such interference, infringement, misappropriation, or violation
(including any claim that the Company must license or refrain from using any
Intellectual Property rights of any third party).

               (g) With respect to each item of Intellectual Property required
identified on Part 2.9 of Schedule 1: (i) the item is not subject to any
outstanding injunction, judgment, order, decree, ruling, or charge; (ii) no
action, suit, proceeding, hearing, investigation, charge, complaint, claim, or
demand is pending or is threatened which challenges the legality, validity,
enforceability, use, or ownership of the item; and (iii) the Company has never
agreed to indemnify any person for or against any interference, infringement,
misappropriation, or other conflict with respect to the item.

               (h) (i) No claim with respect to the Intellectual Property, any
trade secret material to the Company, or any Intellectual Property License which
would adversely affect the ability of the Company to conduct its business as
presently conducted and as proposed to be conducted is currently pending has
been asserted, or overtly threatened by any Person, nor does

<PAGE>

Seller know of any grounds for any claim against the Company, (A) to the effect
that any operation or activity of the Company presently occurring or
contemplated, including, inter alia, the manufacture, use or sale of any
product, device, instrument, or other material made or used according to the
patents or patent applications included in the Intellectual Property or
Intellectual Property Licenses, infringes or misappropriates any United States
or foreign copyright, patent, trademark, service mark or trade secret; (B) to
the effect that any other Person infringes on the Intellectual Property or
misappropriates any trade secret or know-how or other proprietary rights
material to the Company; (C) challenging the ownership, validity or
effectiveness of any of the Intellectual Property or trade secret material of
the Company; or (D) challenging the license of the Company or other legally
enforceable right under, any Intellectual Property or the Intellectual Property
Licenses.

                    (ii) Seller is not aware of any presently existing United
States or foreign patents or any patent applications, which if issued as patents
would be infringed by any activity contemplated by the Company.

               (i) All the patents and patent applications of the Company or any
of its Affiliates or Subsidiaries (the "Patents and Applications") have been
properly prepared and filed on behalf of the Company or any of its Affiliates or
Subsidiaries and are being diligently pursued by the Company or any of its
Affiliates or Subsidiaries. The inventions described in the Patents and
Applications are assigned or licensed to the Company or any of its Affiliates or
Subsidiaries and no other entity or individual has any right or claim in any of
the inventions, Patents and Applications or any patents to be issued therefrom.
Seller is not aware of any material defects in any of the Patents and
Applications which would cause any of them to be held invalid or unenforceable.
There is no objection or proceeding, pending or threatened, that would affect
the validity of any patent issued pursuant thereto.

               (j) Except in connection with the prosecution of the patent
applications listed on Part 2.9 of Schedule 1 hereto, there are no pending
judicial or governmental proceedings, including but not limited to interferences
and oppositions, relating to any of the Patents and Applications or any other
proprietary information to which the Company is a party or by which any property
(such term "property" specifically to include rights pursuant to licenses or
options or other rights to acquire licenses) of the Company are subject, and no
such proceedings are threatened or contemplated by Governmental Authorities or
other Persons.

               (k) Seller has no knowledge of any new products, inventions,
procedures, or methods of manufacturing or processing that any competitors or
other third parties have developed which reasonably could be expected to
supersede or make obsolete any product or process of any of the Company.

          2.10 Labor Relations; Employees.

               (a) Part 2.10 of Schedule 1 hereto (i) sets forth the name, date
of employment, job title, the monthly compensation, and any bonuses of each
regular, full-time and part-time employee of the Company as of the date hereof;
(ii) lists all employment, managerial, advisory, and consulting agreements,
employee confidentiality or other agreements protecting proprietary processes,
formulae, or information to which the Company is a party, and any

<PAGE>

employee handbook(s) published by the Company; (iii) lists every employee of the
Company on authorized leaves of absence who has a right to return to employment,
every contract employee or temporary employee; and (iv) sets forth the name,
office and years of service for each officer and each director of the Company.

               (b) To Seller's best knowledge, the Company is not in violation
of any federal, state or other applicable Law respecting employment, social
security or employment practices relating to its own employees or to the
employees of any of its subcontractors.

               (c) To Seller's best knowledge, the Company is not delinquent in
payments to any of its employees for any wages, salaries, commissions, bonuses
or other direct compensation for any services performed by them to the date
hereof or amounts required to be reimbursed to such employees, (ii) there is no
unfair labor practice complaint against the Company pending before any
Governmental Authority, (iii) there is no labor strike, dispute, slowdown or
stoppage actually pending or threatened against or involving the Company, (iv)
the Company is not a party to or bound by any collective bargaining agreement
and neither any grievance nor any arbitration proceeding arising out of or under
a collective bargaining agreement is pending and no such claim has been
asserted, (v) no labor union currently represents the employees of the Company
and no labor union has taken any action with respect to organizing the employees
of the Company, (vi) no key employee has informed the Company that such employee
will or may terminate his or her employment or engagement with the Company and
(vii) except as otherwise described in this Agreement, there are no payments of
benefits to the employees of the Company above or different from the statutory
benefits corresponding under the applicable labor law.

               (d) To Seller's best knowledge, the Company has filed or caused
to be filed all social security returns required under the statutes, rules or
regulations of the jurisdiction of its incorporation and all other applicable
jurisdictions. All amounts shown in said returns to be due and all additional
demands received prior to the date hereof have been paid in due time and all
withholdings required to be made prior to the date hereof have been duly made
and paid in due time. The amounts set up as accruals for social security
contributions in the Financial Statements are sufficient for the payment of all
accrued and not yet paid amounts.

          2.11 Litigation. Except as set forth in Part. 2.11 of Schedule 1 (i),
there is no action, suit, proceeding, investigation or governmental approval
process (collectively, "Actions") pending or, to the best knowledge of Seller,
threatened or which could be threatened against the Company, or affecting any of
the properties or assets of the Company (including, without limitation, any of
its Permits) which individually or in the aggregate could have a material
adverse effect on the Condition of the Company, nor is there any basis for any
such Action; and (ii) there is no Action against any director, officer or
employee of the Company in connection with the business of such Company which,
in the event of an adverse judgment against any such Person, could have a
material adverse effect on the Condition of the Company, nor is there any basis
for any such Action. The foregoing includes, without limitation, any Action
pending or threatened (or any basis therefor known to the Company) involving the
prior employment of any employees of the Company, their use in connection with
the business of the Company of any information or techniques allegedly
proprietary to any of their former employers, or their obligations under any
agreements with prior employers. To the best knowledge of Seller, neither

<PAGE>

the Company nor any of its respective assets or properties, nor, in connection
with its business, any shareholder, director, officer or employee of the
Company, is subject to any order, judgment, writ, injunction, compliance
agreement, decree, ruling or decision (collectively, an "Order") of any
Governmental Authority which is material to the Condition of the Company. There
is no Action by the Company currently pending or which the Company intends to
initiate, which is material to the Condition of the Company.

          2.12 Compliance with Laws; Permits. To the best knowledge of Seller,
the Company has not violated or failed to comply with, in any material respect,
any law, statute, treaty, ordinance, rule, regulation or policy, domestic or
foreign, of any Governmental Authority (collectively, "Laws") to which it or any
of its properties or assets is subject. The Company has all federal, state,
local and foreign government licenses, permits, orders, certificates
authorizations and approvals of any Governmental Authority (collectively, the
"Permits") that are necessary for the conduct of its business as presently
conducted except to the extent the failure to have any such Permit would not
materially adversely affect the Condition of the Company; all such Permits are,
and as of the Closing will be, in full force and effect; no violations or
notices of failure to comply have been issued or recorded in respect of any such
Permits; there are no proceedings pending, threatened, to revoke, suspend or
limit any such Permit, nor is there any reasonable basis therefor. All
applications, reports, notices and other documents required to be filed by the
Company with all Governmental Authorities on or before the date hereof have been
timely filed and are complete and correct in all material respects as filed or
as amended prior to the date hereof, except to the extent the failure to timely
make such filings or the incompletion of such filing would not materially
adversely affect the Condition of the Company. With respect to any required
Permits, applications for which are either pending or contemplated to be made
pursuant to the business strategy of the Company, none of Seller or the Company
knows of any reason why such Permits should not be approved and granted by the
appropriate Governmental Authority. Neither the Company nor any of its officers
or agents has made any illegal or improper payments to, or provided any illegal
or improper inducement for, any governmental official or other Person in an
attempt to influence any such Person to take or to refrain from taking any
action relating to the Company. Part 2.12 of Schedule 1 lists all Permits of the
Company that are required for the conduct of its business.

          2.13 Taxes. Except as set forth on Part 2.13 of Schedule 1 and to the
best knowledge of Seller (i) all foreign and domestic federal, state, city,
county, local and foreign income, franchise, sales, use and value added tax
returns and reports, and all other tax returns, reports and statements required
to be filed by the Company in those or in any other foreign or domestic
jurisdiction (collectively, "Returns") have been timely filed; (ii) all such
Returns are true, correct and complete in all material respects; (iii) all
taxes, assessments, fees, interest, penalties and other charges of kind
whatsoever (collectively, "Taxes") due or claimed to be due from the Company
have been paid except to the extent properly reserved against on the Financial
Statements; and (iv) no income tax return of the Company has been audited by any
Governmental Authority, and there are in effect no waivers of the applicable
statute of limitations for Taxes in any jurisdiction for the Company for any
period.

          2.14 Books and Records. The books of account, ledgers and records of
the Company accurately and completely reflect in all material respects all
information relating to its business, the nature, acquisition, maintenance,
location and collection of its assets, and the nature

<PAGE>

of all transactions giving rise to its obligations or accounts receivable. The
minute books of the Company fully set forth all action taken by the Board of
Directors, shareholders and, if any, executive board (or other committee
thereof) of the Company.

          2.15 Transactions with Affiliates. Except as set forth in Part 2.15 of
Schedule 1, the Company does not have any obligation to or claim against any
past or present Principal Owner of the Company, or any of such Principal Owner's
Affiliates, associates or relatives, and no such Person has any obligation to or
claim against the Company. All products, services or benefits provided to the
Company by any such Person, or provided by the Company to any such Person, are
set forth on Part 2.15 of Schedule 1 and are provided at a charge equal to the
fair market value of such products, services or benefits. No past or present
Principal Owner of the Company, nor any of such Principal Owner's Affiliates,
associates or relatives, has any direct or indirect interest of any kind in any
business or entity, which is competitive with the Company.

          2.16 No Brokers or Finders. Seller has not entered into or will not
enter into any agreement pursuant to which any of HBDB or the Company will be
liable, as a result of the transactions contemplated by this Agreement, for any
claim of any person for any commission, fee or other compensation as finder or
broker.

          2.17 Employment of Officers, Employees and Consultants. No third party
has any valid claim against the Company, HBDB or any Designated Person (as
hereinafter defined) with respect to (a) the continued employment by, or
association with, the Company, of any of the present officers or employees of or
consultants to the Company (collectively, the "Designated Persons") or (b) the
use, in connection with the business of the Company as presently conducted or
proposed to be conducted by the Company or any of the Designated Persons of any
information which the Company or any of the Designated Persons would be
prohibited from using under any prior agreements or arrangements or any legal
considerations applicable to unfair competition, trade secrets or proprietary
information. Each employee and consultant of the Company has executed an
agreement with the Company (in form and substance satisfactory to HBDB) agreeing
to maintain the confidentiality of proprietary information and agreeing to
assign certain inventions to the Company.

          2.18 Insurance. The Company presently maintains and has maintained in
effect since its formation all the insurance policies required by applicable law
or reasonably appropriate in connection with the operation of its business as
presently conducted.

          2.19 Absence of Undisclosed Liabilities. The Company does not have any
obligation, indebtedness, commitment, guaranty, and other item constituting a
liability under US GAAP, whether direct or indirect, absolute, accrued,
contingent, or otherwise, and whether due or to become due (each, a "Liability")
of any nature whatsoever except for (a) Liabilities reflected or reserved
against in the balance sheet as of October 31, 2001 (the "Balance Sheet"), or
(b) Liabilities and obligations incurred by the Company and not required by US
GAAP to be set forth in the Balance Sheet for the appropriate period, or (c)
Liabilities incurred in the ordinary course of business and consistent with past
practice after the date of the Balance Sheet.

          2.20 Disclosure. In connection with the purchase of the Common Stock
by HBDB as contemplated hereby, the Company and Seller have disclosed to HBDB
all material

<PAGE>

facts and information concerning the Company, its Condition and the Common
Stock, and have not made any untrue statement of a material fact or omitted to
state any material fact necessary in order to make the statements contained
herein not misleading. There is no fact or circumstance which has, or is
reasonably likely to have, an adverse effect on the Company which has not been
disclosed herein.

          2.21 Security Matters

               (a) The HBDB Shares are received by Seller for investment
purposes for his own account, and not with the view to, or for resale in
connection with, any distribution thereof. Seller understands that the HBDB
Shares have not been registered under the Securities Act of 1933, as amended
(the "Securities Act"), or under the securities laws of various states, by
reason of a specified exemption from the registration provisions thereunder.

               (b) Seller acknowledges that the HBDB Shares must be held
indefinitely unless they are subsequently registered under the Securities Act
and under applicable state securities laws or an exemption from such
registration is available. Seller has been advised or is aware of the provisions
of Rule 144 promulgated under the Securities Act which permits limited resale of
the securities purchased in a private placement subject to the satisfaction of
certain conditions including, among other things, the availability of certain
current public information about HBDB and compliance with applicable
requirements regarding the holding period and the amount of securities to be
sold and the manner of sale. Notwithstanding the foregoing, Seller shall enter
into a Lock-Up Agreement attached as Exhibit A with the Company whereby Seller
agrees not to sell his/her/its HBDB for a period of time specified in the
Lock-Up Agreement.

               (c) Seller is a sophisticated investor with knowledge and
experience in business and financial matters and is able to bear the economic
risk and lack of liquidity inherent in owning the HBDB Shares.

               (d) Seller has received and carefully reviewed all HBDB's filings
with Securities and Exchange Commission.

               (e) Seller is aware that no federal or state or other agency has
passed upon or made any finding or determination concerning the fairness of the
transactions contemplated by this Agreement or the adequacy of the disclosure of
the exhibits and schedules hereto.

               (f) Seller understands and acknowledges that neither the Internal
Revenue Service nor any other tax authority has been asked to rule on nor has it
ruled on the tax consequences of the transactions contemplated hereby.

               (g) Seller represents and covenants that he is an "Accredited
Investor" as the term is defined in Rule 501(a) of Regulation D under the
Securities Act.

               (h) Seller understands that all certificates for HBDB Shares
shall bear a legend in substantially the following form:

     "THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
     1933, AS AMENDED, OR QUALIFIED UNDER ANY STATE SECURITIES

<PAGE>

     LAWS. THE SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE
     DISPOSED OF WITHOUT SUCH REGISTRATION OR THE DELIVERY TO THE ISSUER OF AN
     OPINION OF COUNSEL, SATISFACTORY TO THE ISSUER, THAT SUCH DISPOSITION WILL
     NOT REQUIRE REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT OF
     1933, AS AMENDED, OR ANY STATE SECURITIES LAWS."

     3. Representations, Warranties and Agreements of HBDB. HBDB, hereby
represents and warrants to, and agrees with Seller, except as set forth on the
Schedule of Exceptions furnished to Seller and attached hereto as Schedule 5,
specifically identifying the relevant subsection hereof, which exceptions shall
be deemed to be representations and warranties as if made hereunder, as follows:

          3.1 Organization, Good Standing and Qualification. HBDB, is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware. HBDB has all requisite power and authority to carry on
its business as now conducted and as proposed to be conducted. HBDB has all
requisite power and authority to enter into and perform this Agreement and the
transactions contemplated hereby. HBDB is duly qualified to transact business
and is in good standing in each jurisdiction in which the failure so to qualify
could have a material adverse effect on its Condition.

          3.2 Capitalization. The authorized capital stock of HBDB consists of
and upon the consummation of the Closing shall consist of 11,111,111 shares of
common stock, $.002 par value per share, of which currently 348,563 are issued
and outstanding. All of the issued shares are fully paid and non-assessable.
Except as set forth in Part 3.2 of Schedule 5, HBDB does not have outstanding
any securities convertible into or exchangeable for its capital stock or
outstanding any rights to subscribe for or to purchase, or any options for the
purchase of, or any agreements providing for the issuance (contingent or
otherwise) of, or any calls, commitments or claims of any character relating to,
its capital stock. There are no agreements among the shareholders of HBDB with
respect to the voting or transfer of the capital stock or to change control of
HBDB and none of its shareholders has preemptive rights. Schedule 5 hereto
includes a complete and correct list as of immediately prior to the Closing, of
the name of each of HBDB's shareholders and the number of shares of stock owned
by such shareholder. The HBDB Shares are, and at the Closing will be, free and
clear, from any Liens. Except as set forth in part 3.2 of Schedule 5, there is
not outstanding any security, option, warrant, right, agreement, understanding
or commitment of any kind entitling any person or entity to acquire any of the
HBDB Shares. The HBDB Shares have not been registered with the SEC or any state
regulatory authority and no such registration is required.

          3.3 Authority; Execution and Delivery; Requisite Consents,
Nonviolation.

          HBDB has, and at the Closing will have, all requisite power and
authority to execute, deliver and perform this Agreement and each other document
or instrument executed by it, or any of its officers, in connection herewith or
therewith or pursuant hereto or thereto and to consummate the transactions
contemplated hereby and thereby. The execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated hereby and
thereby have been duly and validly authorized by all necessary action on the
part of HBDB.

<PAGE>

This Agreement is duly executed and delivered by HBDB and is the legal, valid
and binding obligation of HBDB, enforceable against HBDB in accordance with its
terms, except as the enforceability thereof may be limited by bankruptcy,
insolvency, moratorium or other similar laws affecting the enforceability of
creditors' rights in general or by general principles of equity. The execution,
delivery and performance of this Agreement, the consummation by HBDB of the
transactions contemplated hereby and thereby (including, without limitation, the
offer, sale and delivery by HBDB of the HBDB Shares) will not (a) require the
consent, license, permit, waiver, approval, authorization or other action of, by
or with respect to, or registration, declaration or filing with, any
Governmental Authority or any other Person; (b) contravene (i) any requirement
of law to which it is subject, including the securities laws of any jurisdiction
or the rules or regulations of any governmental entity or self regulatory body
nor (ii) any judgment, decree, franchise, order or demand applicable to it (c)
conflict or be inconsistent with or result in any breach of the terms,
covenants, conditions or provisions of, or constitute a default under, or result
in the creation or imposition of (or the obligation to create or impose) any
lien upon any of its properties or assets pursuant to the terms of any
indenture, mortgage, deed of trust agreement or other instrument to which it is
a party or bound or to which it may be subject or violate any provision of its
organization documents. HBDB is not in default with respect to any applicable
statute, rules, writ, injunction, decree, order or regulation of any
governmental authority having jurisdiction over it which is likely to adversely
affect its ability to perform its obligations hereunder and entering into this
Agreement will not violate any of them.

          3.4 SEC Filings. Financial Statements. HBDB has filed for the last
twelve (12) months all reports required to be filed by it with the SEC
(collectively, the "HBDB SEC Reports"). As of the respective dates they became
effective, HBDB SEC Reports which were filed pursuant to the Securities Act and
as of the respective dates of filing of the last applicable amendment thereto,
HBDB SEC Reports which were filed pursuant to the Securities Exchange Act of
1934 (the "Exchange Act") did not contain any untrue statement of a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading. To the
best knowledge of HBDB, the financial statements of HBDB included in HBDB SEC
Reports complied as to form in all material respects with the applicable
published rules and regulations of the SEC with respect thereto, were prepared
in accordance with generally accepted accounting principles applied on a
consistent basis throughout the periods involved (except as otherwise noted
therein) and fairly present the consolidated financial position of HBDB as at
the dates thereof and the results of operations and cash flows for the periods
then ended, except that in the case of the unaudited financial statements
included in any form 10-Q, the presentation and disclosure conform with the
applicable rules of the Exchange Act and are subject to year-end adjustments.

          3.5 No Brokers or Finders. HBDB has not and will not enter into any
agreement pursuant to which the Company or Seller will be liable, as a result of
the transactions contemplated by this Agreement, for any claim of any person for
any commission, fee or other compensation as finder or broker.

     Nothing contained in this Section 3 shall in any respect limit or modify
the representations, warranties and agreements of Seller in Section 2 of this
Agreement or the right of HBDB to rely thereon.

<PAGE>

     4. Conditions of HBDB's Obligations at Closing. The obligation of HBDB to
purchase the Common Stock to be purchased by it at the Closing is subject to the
fulfillment, to HBDB's satisfaction, prior to or at the Closing, of each of the
following conditions:

          4.1 Representations and Warranties. The representations and warranties
of Seller contained in this Agreement shall be true and correct in all material
respects on the date hereof and on and as of the Closing Date as if made on and
as of such date.

          4.2 Performance. Seller shall have performed and complied in all
material respects with all agreements and conditions required by this Agreement
to be performed or complied with by him prior to or at the Closing.

          4.3 Stock Certificates, Etc. At the Closing, Seller shall have
tendered to HBDB a certificate representing the Common Stock, together with a
stock power, in accordance with Section 1 hereof. The certificate delivered by
Seller shall be in form and substance satisfactory to HBDB and sufficient to
transfer to and vest in HBDB good and valid title to the Common Stock, free and
clear of any Lien.

          4.4 No Material Adverse Change. There shall not have occurred any
material adverse change in the Condition of the Company since the date hereof.

          4.5 Consents. Seller shall have obtained all consents, approvals or
waivers from Governmental Authorities and third Persons necessary for the
execution, delivery and performance of this Agreement and the transactions
contemplated hereby and thereby, all without material cost or other adverse
consequences to the Company.

          4.6 No Actions. No action, proceeding, investigation, regulation or
legislation shall have been instituted, threatened or proposed before any court,
governmental agency or authority or legislative body to enjoin, restrain,
prohibit, or obtain substantial damages in respect of, this Agreement or the
consummation of the transactions contemplated by this Agreement.

          4.7 Compliance Certificate. HBDB shall have received certificates
dated as of the day of the Closing certifying that the conditions specified in
Sections 4.1, 4.2, 4.4, 4.5 and 4.6 have been fulfilled.

          4.8 Proceedings and Documents. All proceedings in connection with the
transactions contemplated hereby and all documents and instruments incident to
such transactions, including but not limited to the Schedules and Exhibits to
this Agreement, shall be satisfactory in substance and form to HBDB and its
counsel, and HBDB shall have received all such counterpart originals or
certified or other copies of such documents as HBDB may reasonably request.

          4.9 Employment Agreements. If elected by HBDB, any person providing
consulting services or being employed by the Company as described in Part 2.10
of Schedule 1 shall have executed employment agreements containing, without
limitation, provisions with regard to non-competition, non-solicitation, and
inventions, in each case in form and substance satisfactory to HBDB.

<PAGE>

          4.10 Due Dilligence Review.

     HBDB shall have completed, satisfactory to HBDB, due diligence of the
Company.

          4.11 Lock-Up Agreement. Seller shall have entered into a lock-up
agreement, the form of which is attached as Exhibit A.

     5. Conditions of Seller's Obligations at Closing. The obligations of Seller
to HBDB under this Agreement are subject to the fulfillment, to Seller 's
satisfaction, prior to or at the Closing, of each of the following conditions:

          5.1 Representations and Warranties. The representations and warranties
of HBDB contained in this Agreement shall be true and correct in all material
respects on and as of the Closing Date as if made on and as of such date.

          5.2 Performance. HBDB shall have performed and complied in all
material respects with all agreements and conditions required by this Agreement
to be performed or complied with by it prior to or at the Closing.

          5.3 Payment of the Common Stock. At the Closing, HBDB shall have
tendered to Seller a certificate representing the HBDB Shares in accordance with
Section 1 hereof. The certificate delivered by HBDB shall be in form and
substance satisfactory to Seller and sufficient to transfer to and to vest in
Seller good and valid title to the HBDB Shares, free and clear of any Lien.

          5.4 No Material Adverse Change. There shall not have occurred any
material adverse change in the Condition of HBDB since the date hereof.

          5.5 No Actions. No action, proceeding, investigation, regulation or
legislation shall have been instituted, threatened or proposed before any court,
governmental agency or authority or legislative body to enjoin, restrain,
prohibit, or obtain substantial damages in respect of, this Agreement or the
consummation of the transactions contemplated by this Agreement.

          5.6 Proceedings and Documents. All proceedings in connection with the
transactions contemplated hereby and all documents and instruments incident to
such transactions shall be satisfactory in substance and form to Seller and
their counsel, and Seller shall have received all such counterpart originals or
certified or other copies of such documents as he may reasonably request.

          5.7 Compliance Certificate. Seller shall have received certificates
dated as of the day of the Closing executed by HBDB certifying that the
conditions specified in Sections 5.1, 5.2, 5.4 and 5.5 have been fulfilled.

          5.8 Private Equity Facility. HBDB shall have signed agreements for the
provision of a private equity financing facility in the amount of $30,000,000
from Prima Capital Growth Fund LLC (the "Private Equity Line").

<PAGE>

     6. Registration Rights.

          6.1 Request for Registration. If at any time after the earlier of (i)
the one year anniversary of the Closing Date or, (ii) the six month anniversary
of a Qualified Offering as defined below (the "Qualified Offering"), HBDB shall
receive a written request (the "Request") sent by Seller that HBDB files a
registration statement under the Securities Act to effect any registration,
qualification or compliance with respect to all or part of the HBDB Shares (the
"Registrable Securities") representing not less than 5% of the outstanding stock
of HBDB on a fully diluted basis and provided that at such time the Request is
made (A) HBDB has raised $75,000,000 of equity in addition to the $30,000,000
available under the Private Equity Line and (B) HBDB has a market capitalization
of at least $200,000,000, then HBDB shall, as expeditiously as practicable, and
in any event within one hundred and twenty (120) days of the receipt of such
Request, use its best efforts to effect a registration statement under the
Securities Act with respect to all Registrable Securities which Seller request
to be registered. For purpose of this Agreement, a Qualified Offering shall mean
an underwritten public offering of shares of HBDB's common stock, in which the
net proceeds to HBDB are not less than $75,000,000.

               (b) If Seller intends to distribute the Registrable Securities
covered by his request by means of an underwriting, Seller shall so advise HBDB
as a part of his Request. HBDB shall select the managing underwriter or
underwriters in such underwriting. Seller proposes to distribute his securities
through such underwriting and shall (together with HBDB as provided herein)
enter into an underwriting agreement in customary form with the underwriter or
underwriters so selected for such underwriting. If the underwriter advises that
marketing factors require a limitation of the number of shares to be
underwritten, the number of shares of Registrable Securities that may be
included in the underwriting shall be reduced as advised by the underwriters.

               (c) HBDB shall be obligated to effect only two (2) registrations
pursuant to a Request under this Section 6.1 (an offering which is not
consummated shall not be counted for this purpose); provided that (i) HBDB shall
not be obligated to effect the second registration Request if it is done within
180 days or less from the first requested offering; (ii) HBDB shall not be
obligated to effect any registration which is requested within 180 days or less
from a registration made by HBDB as described in Section 6.2.

               (d) Notwithstanding the foregoing, if HBDB shall furnish to
Seller a certificate signed by the President or Chief Executive Officer of HBDB
stating that in the good faith judgment of the Board of Directors of HBDB, it
would be seriously detrimental to HBDB for such registration statement to be
filed by reason of a material pending transaction and it is therefore essential
to defer the filing of such registration statement, HBDB shall have the right to
defer such filing for a period of not more than one (1) year after receipt of
the Request

          6.2 HBDB Registration. If (but without any obligation to do so) HBDB
proposes to register any of its stock or other securities under the Securities
Act in connection with the public offering of such securities solely for cash
other than a registration on Form S-8 (or similar or successor form) relating
solely to the sale of securities to participants in a HBDB stock plan or to
other compensatory arrangements to the extent includable on Form S-8 (or similar
or successor form), or a registration on Form S-4 (or similar or successor form)
except for shares

<PAGE>

registered under the Private Equity Line, HBDB shall, at such time, promptly
give Seller written notice of such registration. Upon the written request of
Seller given within twenty (20) days after mailing of such notice by HBDB, HBDB
shall, subject to the provisions of Section 6.5, use its best efforts to cause
to be registered under the Securities Act all HBDB Shares that Seller has
requested to be registered. HBDB shall have no obligation under this Section 6.2
to make any offering of its securities, or to complete an offering of its
securities that it proposes to make. Seller may exercise the rights described in
this Section 6.2 an unlimited number of times.

          6.3 Conditions Precedent  It shall be a condition precedent to the
obligations of HBDB to take any action pursuant to this Agreement with respect
to this Section that Seller furnishes to HBDB such information regarding
himself, the Registrable Securities held by him, and the intended method of
disposition of such securities as shall be required to effect the registration
of such Seller's Registrable Securities. If any registration statement or
comparable statement under the Securities Act refers to Seller, by name or
otherwise, as the holder of any securities of HBDB then, unless counsel to HBDB
advises HBDB that the Securities Act requires that such reference be included in
any such statement, Seller shall have the right to require the deletion of such
reference to himself.

          6.4 Expenses of Registration. All expenses incurred in connection with
registrations, filings or qualifications pursuant to Sections 6.1 and 6.2,
including without limitation all registration, filing and qualification fees,
printers' and accounting fees, fees and disbursements of counsel for HBDB, and
the reasonable fees and disbursements of one counsel (selected by the Initiating
Holder) shall be borne by Seller.

          6.5 Underwriting Requirements. In connection with any offering
involving an underwriting of shares being issued by HBDB, HBDB shall not be
required under Section 6.2 to include any Seller's securities in such
underwriting unless Seller accepts the terms of the underwriting as agreed upon
between HBDB and the underwriters selected by it, and then only in such quantity
as will not, in the opinion of the underwriters, exceed the largest number of
securities requested to be included in such offering which can be sold without
having an adverse effect on such offering by HBDB. If the total number of
securities, including Registrable Securities, requested by Seller to be included
in such offering (or in any other offering in which Seller shall have the right
to include Registrable Securities pursuant to this Section 6) exceeds the
largest number of securities that the underwriters reasonably believe can be
sold without having an adverse effect on such offering, then HBDB shall be
required to include in the offering only that number of such securities,
including Registrable Securities, which the underwriters believe will not have
an adverse effect on such offering, and the number of shares that may be
included in the underwriting shall be allocated as follows: (i) first, that
number of shares sought to be registered by HBDB, and (ii) second, that number
of shares sought to be registered by Seller, in proportion (as nearly as
practicable) to the amount of the Registrable Securities held by Seller.

          6.6 "Market Stand-Off" Agreement. Seller hereby agrees that, during
the period of ninety (90) days following the effective date of a registration
statement of HBDB filed under the Securities Act in connection with an
underwritten offering, he shall not, if requested by HBDB and such underwriter,
sell or otherwise transfer or dispose of (other than to donees,

<PAGE>

affiliates or partners who agree to be similarly bound) any HBDB Shares held by
him except HBDB Shares included in such registration.

          6.7 Indemnification. In the event any Registrable Securities are
included in a registration statement under this Section 6:

               (a) HBDB will indemnify and hold harmless Seller, legal counsel
and accountants for Seller, any underwriter (as defined in the Securities Act)
for Seller and each person, if any, who controls such underwriter within the
meaning of the Securities Act or the Exchange Act, against any losses, claims,
damages or liabilities (joint or several) to which they may become subject under
the Securities Act, the Exchange Act or any state securities laws, insofar as
such losses, claims, damages, or liabilities (or actions in respect thereof)
arise out of or are based upon any of the following statements, omissions or
violations (collectively a "Violation"): (i) any untrue statement or alleged
untrue statement of a material fact contained in such registration statement,
including any preliminary prospectus or final prospectus contained therein or
any amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged
violation by HBDB of the Securities Act, the Exchange Act, any state securities
laws or any rule or regulation promulgated under the Securities Act, the
Exchange Act or any state securities laws; and HBDB will reimburse Seller, the
underwriter or its controlling person for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action; provided, however, that the indemnity
agreement contained in this subsection 6.7 (a) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of HBDB (which consent shall not be
unreasonably withheld), nor shall HBDB be liable in any such case for any such
loss, claim, damage, liability or action to the extent that it arises out of or
is based upon a Violation that occurs in reliance upon and in conformity with
written information furnished expressly for use in connection with such
registration by Seller, the underwriter or the controlling person; provided
further, however, that the foregoing indemnity agreement with respect to any
preliminary prospectus shall not inure to the benefit of any of Seller or
underwriter, or any person controlling such underwriter, from whom the person
asserting any such losses, claims, damages or liabilities purchased shares in
the offering, if a copy of the prospectus (as then amended or supplemented if
HBDB shall have furnished any amendments or supplements thereto) was not sent or
given by or on behalf of Seller or the underwriter to such person, if required
by law so to have been delivered, at or prior to the written confirmation of the
sale of the shares to such person, and if the prospectus (as so amended or
supplemented) would have cured the defect giving rise to such loss, claim,
damage or liability.

               (b) Seller will indemnify and hold harmless HBDB, each of its
directors, each of its officers who has signed the registration statement, each
person, if any, who controls HBDB within the meaning of the Securities Act,
legal counsel and accountants for HBDB, any underwriter and any controlling
person of such underwriter, against any losses, claims, damages or liabilities
(joint or several) to which any of the foregoing persons may become subject,
under the Securities Act, the Exchange Act or any state securities laws, insofar
as such losses, claims, damages or liabilities (or actions in respect thereto)
arise out of or are based upon any Violation, in each case to the extent (and
only to the extent) that such Violation occurs in reliance upon and

<PAGE>

in conformity with written information furnished by Seller expressly for use in
connection with such registration; and Seller will reimburse any person intended
to be indemnified pursuant to this subsection, for any legal or other expenses
reasonably incurred by such person in connection with investigating or defending
any such loss, claim, damage, liability or action; provided, however, that the
indemnity agreement contained in this subsection 6.7(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of Seller (which consent
shall not be unreasonably withheld).

               (c) Promptly after receipt by an indemnified party under this
Section 6.7 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 6.7, deliver to
the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties that may be represented without
conflict by one counsel) shall have the right to retain one separate counsel,
with the fees and expenses to be paid by the indemnifying party, if
representation of such indemnified party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such
counsel in such proceeding. No indemnifying party shall, without the consent of
the indemnified party, consent to entry of any judgment or enter into any
settlement of any such action which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such indemnified party of a
complete and full release from all liability in respect of such claim or
litigation. No indemnified party shall consent to entry of any judgment or enter
into any settlement of any such action the defense of which has been assumed by
an indemnifying party without the consent of such indemnifying party.

               (d) If the indemnification provided for in this Section 6.7 is
held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage or expense referred to
herein, then the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense
in such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage or expense, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission.

               (e) No Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. Notwithstanding anything to the contrary in this Section 6.7,
no indemnified party shall be required, pursuant to this Section 6.7, to
contribute any amount in excess of the net proceeds received by such
indemnifying party from the sale of

<PAGE>

securities in the offering to which the losses, claims, damages, liabilities or
expenses of the indemnified party relate

               (f) The obligations of HBDB and Seller under this Section 6.7
shall survive (i) the completion of any offering of Registrable Securities in a
registration statement under this Section 6.7, (ii) any investigation made by or
on behalf of any indemnified party or by or on behalf of HBDB, and (iii) the
consummation of the sale or successive resale of the Registrable Securities.

     7. Miscellaneous.

          7.1 Indemnification

               (a) Indemnification by Seller. From and after the Closing, Seller
agrees to indemnify, defend and save HBDB, and each of its officers, directors,
employees, agents, affiliates and subsidiaries (each, a "HBDB Indemnified
Party"), harmless from and against, and to promptly pay to an HBDB Indemnified
Party or reimburse an HBDB Indemnified Party for, any and all liabilities,
losses, costs, expenses, interest and fines (including reasonable fees and
expenses of attorneys, accountants and other experts incurred by any HBDB
Indemnified Party in any action or proceeding between such indemnified party and
the indemnitor or between any indemnified party and any third party or
otherwise) (individually a "Loss" and collectively, the "Losses") sustained or
incurred by any HBDB Indemnified Party relating to, resulting from, arising out
of or otherwise by virtue of any breach of a representation or warranty made
herein by Seller or breach or failure to observe or perform any of the covenants
or agreements made by him and contained in this Agreement.

               (b) Indemnification by HBDB. From and after the Closing, HBDB
agrees to indemnify, defend and save Seller harmless from and against, and to
promptly pay to Seller or reimburse him for, any and all Losses sustained or
incurred by Seller relating to, resulting from, arising out of or otherwise by
virtue of any breach of a representation or warranty made herein by HBDB or the
covenants or agreements of HBDB contained in this Agreement.

               (c) Procedure for Indemnification. The following procedure shall
apply to the foregoing agreements to indemnify and hold harmless:

               (1) The party who is seeking indemnification (the "Claimant")
shall give written notice to the party from whom indemnification is sought (the
"Indemnitor") promptly after the Claimant learns of the claim or proceeding,
provided that the failure to give such notice shall not relieve the Indemnitor
of its obligations hereunder except to the extent it is actually damaged
thereby.

               (2) With respect to any third-party claims or proceedings as to
which the Claimant is entitled to indemnification after satisfaction of any
applicable Basket, as defined below, the Indemnitor shall have the right to
select and employ counsel of its own choosing to defend against any such claim
or proceeding, to assume control of the defense of such claim or proceeding, and
to compromise, settle or otherwise dispose of the same, if the Indemnitor deems
it advisable to do so, all at the expense of the Indemnitor. No settlement,
compromise or

<PAGE>

disposition shall be made without the prior consent of the Claimant, which
consent shall not be unreasonably withheld; provided, however, no consent need
be given if there is not a general release given to the Claimant or if any
injunctive relief is imposed on the Claimant. The parties will fully cooperate
in any such action, and shall make available to each other any books or records
useful for the defense of any such claim or proceeding. The Claimant may elect
to participate in the defense of any such third party claim, and may, at its
sole expense, retain separate counsel in connection therewith. Subject to the
foregoing the Claimant shall not settle or compromise any such third party claim
without the prior consent of the Indemnitor, which consent shall not be
unreasonably withheld.

               (d) Limitation on Indemnification Rights.

               (1) It is understood and agreed that no claim for recovery of
indemnifiable damages may be asserted based on a representation, warranty or
applicable portion thereof set forth in this Agreement after it has been
extinguished in accordance with Section 7.1 (d) (2) hereof, except as to any
matters with respect to which a bona fide written claim shall have been made or
an action at law or in equity shall have commenced before such date, in which
event survival shall continue (but only with respect to and to the extent of,
such claim or action) until the final resolution of such claim or action,
including all applicable periods of appeal.

               (2) Notwithstanding any other provision of this Agreement,
neither party shall be entitled to indemnification from the other under the
provisions of this Section 7.1 until the aggregate of any and all Losses
suffered by HBDB Indemnified Parties or by Seller exceeds the sum of $50,000
(the "Basket"), whereupon the HBDB Indemnified Parties or Seller shall
thereafter be entitled to indemnification for all Losses suffered by them which
arise under the provisions of Section 7.1 (a) on a dollar-for-dollar basis
(other than the above-described one-time $50,000 deductible) as they occur;
provided that such requirement of an aggregate of $50,000 of Losses shall not
apply to Losses in the case of fraud or for breach of the representations in
Section 2.1, 2.2, 2.3, 2.4, 2.9, 2.13, 2.20 and Section 3.1, 3.2 and 3.3.

               (e) Remedy for Damages. The indemnification obligations of the
parties set forth in this Section 7.1 shall not constitute the sole and
exclusive remedies of the parties for the recovery of money damages with respect
to any and all matters arising out of this Agreement. Notwithstanding the
foregoing, the terms of this Section 7.1 shall not be construed as limiting in
any way whatsoever any remedy to which any party may be entitled other than the
recovery of money damages, including but not limited to equitable remedies,
specific performance, injunctive relief and rescission.

          7.2 Survival. All representations, warranties, covenants and
agreements contained in or made pursuant to this Agreement or contained in any
certificate delivered pursuant to this Agreement, shall remain operative and in
full force and effect, regardless of any investigation made by or on behalf of
any party hereto, and shall survive the transfer and payment for the Common
Stock and the consummation of the transactions contemplated hereby for a period
of 12 months, unless a claim is made prior thereto.

          7.3 Assignment. This Agreement and all the provisions hereof shall be
binding upon and shall inure to the benefit of the parties hereto and their
respective successors and

<PAGE>

assigns. Any assignees or successors shall take any such assignment(s) subject
to all obligations of the assigning or original party and subject to any and all
defenses. Nothing herein shall relieve an assigning party of its obligations
under this Agreement.

          7.4 Amendment; Waiver. Any term, covenant, agreement or condition of
this Agreement may be amended, and compliance therewith may be waived (either
generally or in a particular circumstance and either retroactively or
prospectively), by one or more substantially concurrent written instruments
signed by Seller and HBDB. Any amendment or waiver effected in accordance with
this paragraph shall be binding upon each of Seller and HBDB.

          7.5 Governing Law This agreement shall be governed by and construed
and enforced in accordance with, the laws of the State of New York, without
regard to conflicts of law principles. Any disputes with respect to the
interpretation of this Agreement or the rights and obligations of the parties
hereto shall be exclusively brought in the U.S. District Court for the Southern
District of New York or if such court lacks subject matter jurisdiction, in the
Supreme Court of the County of New York. Each of the parties waives any right to
object to the jurisdiction or venue of either of such Courts or to claim that
such Courts are an inconvenient forum.

          7.6 Exchange of HBDB Shares. It is intended that after the effect of
the transactions described herein and other transactions which HBDB intends to
enter into with the remaining Company's shareholders (collectively with Seller,
the "Group"), the Group will, in the aggregate, own 96.25% of the equity
interest of HBDB and the current shareholders of HBDB will own the remaining
3.75% of the equity interest of HBDB; provided that such capital structure is
subject to dilution by reason of (i) the issuance of shares of common stock
under the Private Equity Line; (ii) the issuance of 600,000 registered warrants,
issued at $1.00 per share; (ii) the exercise of the options to acquire shares of
common stock as set forth in HBDB's stock option plan and (iii) the issuance of
debt convertible into equity of HBDB, as approved from time to time by HBDB's
Board of Directors. For any further issuance of securities of HBDB, Seller
acknowledges that HBDB will exchange shares of common stock at a ratio of 3.0
HBDB's shares of common stock for each Company share of common stock.

          7.7 Amendment; Waiver. Any term, covenant, agreement or condition of
this Agreement may be amended, and compliance therewith may be waived (either
generally or in a particular circumstance and either retroactively or
prospectively), by one or more substantially concurrent written instruments
signed by Seller and HBDB. Any amendment or waiver effected in accordance with
this paragraph shall be binding upon each of Seller and HBDB.

          7.8 Notices. All notices and other communications provided for herein
shall be dated and in writing and shall be deemed to have been duly given (x) on
the date of delivery, if delivered personally or by telecopier, receipt
confirmed, (y) on the second following business day, if delivered by a
recognized overnight courier service, or (z) seven days after mailing, if sent
by registered or certified mail, return receipt requested, postage prepaid, in
each case, to the party to whom it is directed at the following address (or at
such other address as any party hereto shall hereafter specify by notice in
writing to the other parties hereto):

          (i) If to HBDB, to it at the following address:

<PAGE>

                              HBDB Corporation
                              9845 N.E. 2nd Avenue
                              Miami Shores, FL 33138
                              Tel: (305) 759-8710
                              Attention: John Taggart

                    with a copy to:

                              Proskauer Rose LLP
                              1585 Broadway
                              New York, New York 10036
                              Attention: David W. Sloan

          (ii) If to Seller, to them at the following address:

                              Tony Milici
                              9053 Gray Fox Dr
                              Evergreen, Co. 80439

          7.9 Integration. Exhibits. This Agreement and the documents referred
to herein or delivered pursuant hereto or pursuant to such documents, including
all exhibits and schedules, contain the entire understanding of the parties with
respect to their subject matter and supersede all prior agreements and
understandings between the parties with respect to their subject matter. It is
understood that the Schedules and Exhibits referred in this Agreement are not
attached to this Agreement concurrently with its signature thereof, and as
provided in Section 4.8 hereof, it is a condition for HBDB to close the
transactions described in this Agreement to have received the Schedules and
Exhibits in a satisfactory form for HBDB.

          7.10 Severability. Each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement is held to be prohibited or invalid under
applicable law, such provision will be ineffective only to the extent of such
prohibition or invalidity, without invalidating the remainder of this Agreement.

          7.11 Descriptive Headings. The section and other headings contained in
this Agreement are for convenience of reference only and shall not affect the
meaning or interpretation of this Agreement.

          7.12 Counterparts. This Agreement may be executed in two or more
counterparts, each of which when so executed and delivered shall be deemed to be
an original and all of which together shall be deemed to be one and the same
agreement.

<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.

                                    /s/
                                    -------------------------------------------
                                    HAND BRAND DISTRIBUTION, INC.

                                    By:     John Taggart
                                    Title:  President

                                    SELLER:

                                    /s/
                                    --------------------------------------------
                                    Tony Milici

<PAGE>

                                TABLE OF CONTENTS

Section                                                                    Page

1.  Purchase and Sale of the Common Stock......................................1
    1.1  Sale of the Common Stock..............................................1
    1.2  Closing...............................................................1

2.  Representations, Warranties and Agreements of Seller.......................2
    2.1  Organization, Good Standing and Qualification.........................2
    2.2  Capitalization........................................................2
    2.3  Authority; Execution and Delivery; Requisite Consents, Nonviolation...2
    2.4  Subsidiaries..........................................................3
    2.5  Financial Information.................................................4
    2.6  Certain Changes or Events.............................................5
    2.7  Title to Assets.......................................................5
    2.8  Contracts.............................................................5
    2.9  Intellectual Property.................................................7
    2.10 Labor Relations; Employees...........................................10
    2.11 Litigation...........................................................10
    2.12 Compliance with Laws; Permits........................................11
    2.13 Taxes................................................................12
    2.14 Books and Records....................................................12
    2.15 Transactions with Affiliates.........................................12
    2.16 No Brokers or Finders................................................12
    2.17 Employment of Officers, Employees and Consultants....................12
    2.18 Insurance............................................................13
    2.19 Absence of Undisclosed Liabilities...................................13
    2.20 Disclosure...........................................................13
    2.21 Security Matters.....................................................13

3.  Representations, Warranties and Agreements of HBDB........................14
    3.1  Organization, Good Standing and Qualification........................14
    3.2  Capitalization.......................................................15
    3.3  Authority; Execution and Delivery; Requisite Consents, Nonviolation..15
    3.4  SEC Filings. Financial Statements....................................16
    3.5  No Brokers or Finders................................................16

4.  Conditions of HBDB's Obligations at Closing...............................16
    4.1  Representations and Warranties.......................................16
    4.2  Performance..........................................................16
    4.3  Stock Certificates, Etc..............................................17
    4.4  No Material Adverse Change...........................................17
    4.5  Consents.............................................................17
    4.6  No Actions...........................................................17

<PAGE>

    4.7  Compliance Certificate...............................................17
    4.8  Proceedings and Documents............................................17
    4.9  Employment Agreements................................................17
    4.10 Due Dilligence Review................................................18

5.  Conditions of Seller's Obligations at Closing.............................18
    5.1  Representations and Warranties.......................................18
    5.2  Performance..........................................................18
    5.3  Payment of the Common Stock..........................................18
    5.4  No Material Adverse Change...........................................18
    5.5  No Actions...........................................................18
    5.6  Proceedings and Documents............................................18
    5.7  Compliance Certificate...............................................19
    5.8  Private Equity Facility..............................................19

6.  Registration Rights.......................................................19
    6.1  Request for Registration.............................................19
    6.2  HBDB Registration....................................................20
    6.3  Conditions Precedent.................................................20
    6.4  Expenses of Registration.............................................20
    6.5  Underwriting Requirements............................................20
    6.6  "Market Stand-Off"Agreement..........................................21
    6.7  Indemnification......................................................21

7.  Miscellaneous.............................................................23
    7.1  Indemnification......................................................23
    7.2  Survival.............................................................25
    7.3  Assignment...........................................................25
    7.4  Amendment; Waiver....................................................25
    7.5  Governing Law........................................................25
    7.6  Exchange of HBDB Shares..............................................26
    7.7  Amendment; Waiver....................................................26
    7.8  Notices..............................................................26
    7.9  Integration. Exhibits................................................27
    7.10 Severability.........................................................27
    7.11 Descriptive Headings.................................................27
    7.12 Counterparts.........................................................27

<PAGE>

                                  SCHEDULE LIST

Schedule 1   Schedule of Exceptions for Seller

Schedule 2   Names of Shareholders and holders of Options and/or Warrants, etc.

Schedule 3   List of Subsidiaries

Schedule 4   Financial Statements of the Company

Schedule 5   Schedule of Exceptions for HBDB

                                    EXHIBITS

A.  Form of Lock-Up Letter.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]